Substance-Related Disorder
A chronic disease characterized by uncontrolled drinking and preoccupation Excessive use of psychoactive drugs, such as alcohol, pain medications, or illegal drugs. It can lead to physical, social, or emotional harm.
Cluster Number:
Wiki Number: PW215
Diagnosis: Substance-Related Disorder
US Patients: 7% of adults; 5% for alcohol; 2% for other drugs; 72,000 deaths from drug overdoses in 2017; 88,000 alcohol&480,000 tobacco deaths
World Patients: 2017-271 million (5.5% of adults) have used illicit drugs and 35 million, have an use disorder; 585,000 drug-deaths
Sex Ratio: Alcohol-only disorder 237 million men and 46 million women; 3 million alcohol-related deaths.
Age Onset: Children have 2X substance use disorders if parents hae them vs. parents without them.
Brain Area:
Symptoms: persistent use despite harm and adverse consequences: alcohol, caffeine, pot, phencyclidine, hallucinogens, inhalants, opioids, etc
Progression: can be mild, moderate or severe damage
Causes:
Medications: detox; FDA has 2 for alcohol and opioid use; none for the cocaine, methamphetamine or other substance use disorders
Therapies:
Youtube Video: Substance Use Disorders-Dopamine Pathway
Youtube Video:
Substance Abuse Disorders
Amazon or Library Book:
Stahl’s Illustrated Substance Use and Impulsive Disorders
Support Group: Samhsa.gov; 800-662-4357
(U.S. Government Helpline)
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.02.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Barriers and facilitators to medication-assisted treatment for cocaine use disorder among men who have sex with men: a qualitative studyby Elaine Hsiang on November 21, 2024
CONCLUSIONS: Our study highlights important factors affecting the acceptability and uptake of medication-assisted treatment for CUD among a diverse sample of MSM. These findings can help guide the development and implementation of future pharmacotherapy options for CUD and other substance use disorders in this key population.
- A Qualitative Process Evaluation and Quality Improvement of a State Drug Overdose Reporting System Data Collection Approachby Mircea Lazar on November 21, 2024
Tennessee registered the second-highest drug overdose mortality rate of any state in 2022; such deaths have grown by 90% from 2019 to 2022. Tennessee has participated in the State Unintentional Drug Overdose Reporting System (SUDORS) since 2018. An abstraction team synthesizes data for SUDORS from death certificates, autopsies, and other sources. The purpose of this study was to engage in a comprehensive qualitative evaluation of our SUDORS process to distill insights that could improve...
- Pregabalin in prisons: recommendations for the general practitionerby Jalel Araiedh on November 21, 2024
The misuse of pregabalin (Lyrica) has emerged as a common problem in recent years, particularly among vulnerable populations. This reality is reflected in the prison environment, where pregabalin is subject to abuse and trafficking. In this article, we detail the issues surrounding this misuse and our practical strategy for tackling it. It is based on four axes: a) clarification of the indication (or lack thereof); b) support of withdrawal with gabapentin; c) if applicable, management of the...
- Mandated Substance Use Disorder Treatment in Qatar: An Innovative Model of Careby Majid Alabdulla on November 21, 2024
CONCLUSION: The innovative Recovery Journey model at the Umm Slal Treatment and Rehabilitation Center demonstrated promising results in treating individuals with substance use disorders. While initial outcomes are encouraging, challenges related to stakeholder engagement, treatment adherence, and post-discharge care remain. This model emphasizes the importance of balancing directed care with patient autonomy and may serve as a framework for similar initiatives in the region. Further research...